Regulus Therapeutics
Nov. 26, 2024
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity Regulus Announces Pricing of Public Offering of Common Stock Regulus Therapeutics Company Profile: Stock Performance & Earnings | PitchBook Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics - Sanofi (NASDAQ:SNY) - Benzinga | Regulus Therapeutics
![1.39|1.45] Regulus Therapeutics Inc.](https://www.tradegate.de/images/charts/monat/US75915K3095.png?1708385520){kind=link}
![1.39|1.45] Regulus Therapeutics Inc.](https://www.tradegate.de/images/charts/jahr/US75915K3095.png?1708385520){kind=link}
![1.39|1.45] Regulus Therapeutics Inc.](https://www.tradegate.de/images/charts/5jahre/US75915K3095.png?1708385520){kind=link}
